Skip to main content
. 2019 Oct 15;22(8):1374–1382. doi: 10.1093/ntr/ntz170

Figure 2.

Figure 2.

Between-visit point prevalence abstinence during treatment and 7-day point prevalence abstinence at post-treatment follow-up visits for the intent to treat sample of cannabis users by baseline cannabis use frequency. Noncannabis users (n = 50), infrequent cannabis users (n = 73), and frequent cannabis users (n = 34).